Shikiar Asset Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18K | Hold |
15,750
| – | – | 0.01% | 77 |
|
|
2025
Q1 | $23K | Hold |
15,750
| – | – | 0.01% | 75 |
|
|
2024
Q4 | $34K | Hold |
15,750
| – | – | 0.01% | 76 |
|
|
2024
Q3 | $44K | Hold |
15,750
| – | – | 0.01% | 73 |
|
|
2024
Q2 | $37K | Hold |
15,750
| – | – | 0.01% | 70 |
|
|
2024
Q1 | $70K | Hold |
15,750
| – | – | 0.02% | 72 |
|
|
2023
Q4 | $51K | Hold |
15,750
| – | – | 0.02% | 70 |
|
|
2023
Q3 | $50K | Hold |
15,750
| – | – | 0.02% | 75 |
|
|
2023
Q2 | $78K | Sell |
15,750
-7,500
| -32% | -$37.1K | 0.03% | 76 |
|
|
2023
Q1 | $115K | Buy |
+23,250
| New | +$115K | 0.04% | 75 |
|
|
2022
Q3 | $251K | Hold |
23,250
| – | – | 0.1% | 72 |
|
|
2022
Q2 | $265K | Hold |
23,250
| – | – | 0.1% | 80 |
|
|
2022
Q1 | $212K | Hold |
23,250
| – | – | 0.06% | 91 |
|
|
2021
Q4 | $347K | Sell |
23,250
-1,535
| -6% | -$22.9K | 0.09% | 78 |
|
|
2021
Q3 | $637K | Sell |
24,785
-3,100
| -11% | -$79.7K | 0.18% | 63 |
|
|
2021
Q2 | $727K | Buy |
27,885
+3,100
| +13% | +$80.8K | 0.21% | 61 |
|
|
2021
Q1 | $875K | Sell |
24,785
-10,500
| -30% | -$371K | 0.3% | 53 |
|
|
2020
Q4 | $891K | Buy |
35,285
+5,060
| +17% | +$128K | 0.32% | 48 |
|
|
2020
Q3 | $1.14M | Sell |
30,225
-100
| -0.3% | -$3.77K | 0.44% | 41 |
|
|
2020
Q2 | $1.3M | Buy |
30,325
+2,000
| +7% | +$85.7K | 0.59% | 35 |
|
|
2020
Q1 | $551K | Sell |
28,325
-7,320
| -21% | -$142K | 0.37% | 44 |
|
|
2019
Q4 | $926K | Buy |
35,645
+650
| +2% | +$16.9K | 0.31% | 49 |
|
|
2019
Q3 | $954K | Sell |
34,995
-8,400
| -19% | -$229K | 0.38% | 50 |
|
|
2019
Q2 | $1.17M | Sell |
43,395
-8,390
| -16% | -$225K | 0.46% | 48 |
|
|
2019
Q1 | $1.5M | Buy |
51,785
+12,585
| +32% | +$364K | 0.63% | 39 |
|
|
2018
Q4 | $1.06M | Buy |
+39,200
| New | +$1.06M | 0.55% | 38 |
|